Dz13: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +) |
|||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Dz13''' is an experimental treatment developed by Australian scientists which aims to combat a range of illnesses from [[diabetes]] to [[Heart Disease|heart disease]] and [[cancer]]. | '''Dz13''' is an experimental treatment developed by Australian scientists which aims to combat a range of illnesses from [[diabetes]] to [[Heart Disease|heart disease]] and [[cancer]]. | ||
| Line 10: | Line 10: | ||
* [http://www.smh.com.au/news/National/New-super-drug-may-combat-cancer/2006/07/03/1151778858991.html New super drug may combat cancer] | * [http://www.smh.com.au/news/National/New-super-drug-may-combat-cancer/2006/07/03/1151778858991.html New super drug may combat cancer] | ||
[[Category:Experimental medical treatments]] | [[Category:Experimental medical treatments]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 02:02, 9 August 2012
|
WikiDoc Resources for Dz13 |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Dz13 at Clinical Trials.gov Clinical Trials on Dz13 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Dz13
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Dz13 Risk calculators and risk factors for Dz13
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Dz13 is an experimental treatment developed by Australian scientists which aims to combat a range of illnesses from diabetes to heart disease and cancer.
How it works
The treatment works by targeting "c-Jun", a disease causing gene found in diseased blood vessels, eyes, lungs, joints and the stomach, removing it from the DNA in a cell. It has been proven to have a positive effect on skin cancer in patients.